Multi-temperature-zone intelligent regulation and control medical cold chain system

By using multi-layer phase change materials and semiconductor refrigeration components in the pharmaceutical cold chain box, combined with multi-source sensing nodes and adaptive control algorithms, real-time monitoring and dynamic adjustment of multi-temperature zones are achieved, solving the problem that it is difficult to meet the precise temperature requirements of multiple types of preparations in the prior art, and reducing the risk of drug failure and energy consumption.

CN120120798AInactive Publication Date: 2025-06-10ZUNYI MEDICAL UNIVERSITY +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202510464529.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-04-14
Publication Date
2025-06-10
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing pharmaceutical cold chain transportation solutions are difficult to meet the precise requirements of multiple types of preparations for their respective temperature ranges in the same transportation path. Especially in long-distance transportation across regions, it is easy to have the risk of changes in the nature of drugs due to excessive or excessive cold.

Method used

By setting up gradient distribution of multi-layer phase change materials and four-stage or above stacked semiconductor refrigeration components in the cold chain box, combining multi-source sensing nodes and adaptive control algorithms, real-time monitoring and dynamic adjustment of multi-temperature zones are achieved.

Benefits of technology

Differentiated low-temperature demand for a variety of pharmaceutical preparations is achieved, energy consumption and drug failure risks during long-distance cross-region transportation, and a flexible, variable, safe, efficient and highly adaptable data-based transportation solution is provided.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120120798A_ABST
    Figure CN120120798A_ABST
Patent Text Reader

Abstract

The invention provides a multi-temperature-zone intelligent regulation and control medical cold chain system aiming at the problems of differentiated temperature requirements and biological safety in medicine cold chain transportation. The system is based on a multi-stage semiconductor refrigeration technology and a PCMS composite thermal insulation structure, a plurality of temperature zones which can be independently managed are arranged in the same box body, and a multi-source sensor array and an improved thermal coupling equation are combined; partitioned temperature fine control and cooperative energy consumption management are carried out on biological agents (such as vaccines, plasma and pathogen specimens) with different sensitivities and storage and transportation requirements. Layered energy storage and energy release are carried out in multiple temperature intervals through the phase change materials, self-adaptive compensation is carried out on factors such as box vibration, inclination and environment sudden change through a main control algorithm, and the medicine failure risk caused by temperature chain scission and overshoot is remarkably reduced. On the basis, the invention also provides a cloud big data analysis and remote scheduling mechanism, information such as real-time temperature curves, energy consumption indexes and pre-estimated residual cooling capacity of multiple temperature zones can be synchronously uploaded, potential faults and route congestion are automatically identified by means of a distributed algorithm, and then an energy-saving or emergency cooling instruction is issued to the box body. For extreme cryogenic requirements and high-risk pathogen scenes, the stability and the isolation protection level of a cryogenic area can be enhanced through the additional refrigerant circulating unit and the biological safety isolation cabin, and it is ensured that stable low temperature and high safety can still be kept in long-time cross-regional transportation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical cold chain transportation and refined temperature control, aiming to provide a low-temperature environment with coexisting multiple temperature zones and real-time adjustability for various pharmaceutical preparations with different sensitivities and storage and transportation requirements (such as vaccines, plasma, biological products, etc.). Specifically, it covers links such as semiconductor multi-stage refrigeration, composite material thermal insulation design, dynamic data acquisition, and adaptive control strategies. Based on the concept of Internet of Things engineering, the present invention combines sensing measurement, data processing, and the box structure, enabling the cold chain device to achieve precise zoning management and risk warning during the cross-regional transportation of medical products while meeting the requirements of long-term battery life, ultra-low temperature coverage, high safety, and traceability. Through multi-parameter fusion technology, this system can monitor and perform closed-loop correction on the temperature and humidity indicators of multiple temperature zones inside the box and the external environmental state in real time, forming a complete and flexible medical cold chain system. Background Art

[0002] In the fields of medicine and life sciences, blood products, vaccines, biopharmaceuticals, and special detection reagents often have very different requirements for storage temperature ranges. A cryogenic environment as low as minus twenty degrees Celsius or below, or a constant temperature transition zone between two and eight degrees Celsius, may occur simultaneously. However, existing medical cold chain transportation solutions mostly adopt single-zone or layered thermal insulation modes, relying on dry ice, cold storage agents, or mechanical air-cooling systems for single-time cooling, and it is difficult to meet the precise requirements of various preparations for their respective temperature zones in the same transportation route. Especially in long-distance cross-regional transportation, if only a single temperature zone is provided, there is a high risk that some drugs may change their properties due to being over-cooled or not cooled enough. At the same time, the thermal insulation materials of traditional cold chain boxes are mostly ordinary polyurethane foam or polystyrene foam. Although the manufacturing cost is relatively low, it is difficult to maintain a stable low temperature for a long time in extreme environments, and the thermal insulation efficiency drops significantly with the fluctuation of the external air temperature. To extend the battery life, many solutions choose to repeatedly add ice packs or dry ice. However, once passing through areas with large temperature differences or due to operational errors causing the box to be opened frequently, it is difficult to perform real-time temperature control compensation and centralized scheduling, resulting in frequent "broken chains" in the medical cold chain and drug losses.

[0003] In actual use, single-stage or two-stage thermoelectric coolers often face problems such as uneven heat dissipation and heat energy backflow. It is difficult to quickly distribute the cooling capacity to different temperature zones, and there is also a lack of differential environmental management measures for large refrigerated trucks or centralized storage. For drugs such as blood products and insulin that have extremely strict temperature requirements or need deep freezing, there is still a large room for improvement in the refrigeration power, heat preservation reliability, and energy consumption performance of such equipment. On the other hand, although some solutions based on mechanical compression refrigeration can provide strong refrigeration capacity, the entire system is huge and highly dependent on power supply, and it is not suitable for flexible small-batch and multi-batch transportation scenarios. In traditional solutions, information such as the temperature, humidity, geographical location, and box sealing status inside the box is often managed separately by independent data recorders, lacking cross-regional networked integrated monitoring, and it is difficult to accurately respond to sudden failures or biosafety risks in a timely manner. In addition, the requirements of pharmaceutical supervision are becoming increasingly strict, and "traceability throughout the process" and "environmental monitoring" have become industry consensus. However, most of the existing cold chain devices still do not build a complete data collection, abnormal alarm, and cloud analysis system, unable to real-time correct the refrigeration strategy according to the environmental fluctuations during transportation, and lacking deep learning and algorithm compensation for complex temperature curves. To sum up, how to introduce multi-stage refrigeration units in an integrated box to cover different temperature requirements, supplemented by high-efficiency composite thermal insulation materials, online data collection, and remote linkage control, to achieve independent and coordinated "multi-temperature zone dynamic regulation" in each temperature zone has become the key point that the new generation of pharmaceutical cold chain system urgently needs to break through. By adopting four-stage or multi-stage thermoelectric coolers at the hardware level and combining phase change materials with multi-layer thermal insulation structures, and cooperating with temperature and humidity closed-loop monitoring and multi-source fusion algorithms at the software level, it is expected to build a data-based medical cold chain system with long-term endurance, high-precision temperature control, and safety, providing a more flexible and reliable refined transportation environment for biological agents and other medical sensitive items. Summary of the Invention

[0004] Based on multi-stage semiconductor refrigeration and multi-phase change thermal insulation materials, the present invention establishes a multi-temperature zone that cooperates with each other in the same box body. By allocating independent thermal management units to each temperature zone according to the storage and transportation temperature requirements of various pharmaceutical preparations and coordinating them with a unified control core. Specifically, multiple layers of phase change materials with gradient distribution are arranged in the insulation layer of the box body to distinguish low-temperature zones (such as minus 20 degrees to minus 40 degrees), medium-low temperature zones (such as 2 to 8 degrees), and even composite structures that can support deeper cryogenic zones in extreme cases. High-porosity honeycomb fiber isolation membranes and nano-aerogel shielding groups are interspersed between the phase change layers to effectively control the heat conduction paths between each temperature zone and reduce the escape of cold energy to non-target areas. Combined with a semiconductor refrigeration module stacked with four or more levels, the target temperature of each temperature zone can be initially cooled in a very short time. Subsequently, by embedding multi-source sensing nodes (including temperature and humidity sensors, pressure sensors, attitude sensors, box door opening and closing sensors, etc.) inside the box body, the present invention comprehensively inputs these sensing data together with information such as the external climate, the operating state of the transport vehicle, and the material load inside the box into the control algorithm. The control algorithm introduces a thermal coupling compensation model and an adaptive gain scheduling strategy on the basis of referring to the classic PID mechanism, so as to achieve a dynamic balance in the adjustment of the heat dissipation and refrigeration power of each temperature zone. Once the temperature of a certain temperature zone drifts due to external environmental changes or accidental vibrations, the control algorithm will automatically calculate its heat coupling coefficient with adjacent temperature zones and the remaining cold storage energy, quickly call idle refrigeration modules or coordinate the latent heat of phase change reserved in other temperature zones for compensation, realizing the collaborative cold chain management of partitioned thermal insulation and heat sharing. The present invention is also equipped with a visual Internet of Things communication module, which is used to upload the temperature curves, energy consumption indicators, box body safety status, etc. of each temperature zone to the supervision platform in real time and generate corresponding cold chain health scores. If persistent temperature anomalies or biosafety hazards are detected, multi-level alarms will be issued simultaneously locally and in the cloud of the device, and the emergency cold storage device or local isolation measures can be triggered to prevent damage or secondary contamination of highly sensitive drugs. Through this highly integrated multi-temperature zone independent regulation architecture, the present invention can take into account the different low-temperature requirements of various pharmaceutical preparations such as vaccines, plasma, and special biological reagents in the same transport box body, and greatly reduce the energy consumption and drug failure risk during long-distance cross-regional transportation. Finally, it provides a flexible, safe, efficient and highly adaptive data-based transportation solution for the pharmaceutical cold chain industry.

[0005] The present invention further constructs an interrelated multi-layer parsing and self-learning mechanism at the hardware structure and data management levels, enabling the entire medical cold chain system to automatically allocate and dynamically adjust the energy consumption and refrigeration strategies of each temperature zone according to the type of medicine, the loading quantity, and the changes in the external environment. To enhance the refined control of heat transfer inside the box body, the present invention arranges highly sensitive heat flux sensors between the wall body and the phase change material interface of each temperature zone. Based on independent temperature gradient data, the sensor can infer the changes in the local heat penetration coefficient in real time and report them to the control core. After collecting the heat flux, environmental temperature, humidity, and current refrigeration device load information of each temperature zone, the control core uses an improved thermal coupling multi-field coupling model to numerically simulate the possible "leakage" or insufficient distribution of cold in the box body, and identifies the areas most likely to experience temperature fluctuations through iterative solution and linearization approximation methods. After completing the numerical analysis, the present invention will dynamically and precisely allocate the power supply, current amplitude, and PWM duty cycle of the four-stage semiconductor refrigeration device according to the priority relationship of multiple temperature zones and the temperature accuracy requirements of pharmaceutical preparations, and evaluate whether the current remaining latent heat storage of the phase change material is sufficient to maintain the expected temperature range. If it is detected that the load of a certain temperature zone suddenly increases due to carrying a large mass of biological preparations, the control core will activate the controllable heat insulation layer between adjacent temperature zones to reduce unnecessary heat diffusion, and temporarily cut off the low-priority refrigeration requirements of other temperature zones when necessary, concentrating the main power on maintaining the temperature of critical biological active preparations. The present invention also sets a rigid frame with elastic supports at the bottom of the box body to collect acceleration data through the piezoelectric effect during vehicle bumping or turning, and combines it with the information of the attitude sensor to dynamically calibrate the force distribution of the cold chain box body, and compensate in real time for vibrations or tilts that may cause attenuation of temperature uniformity. Based on the information fed back by the frame, the system can increase the safety margin of instantaneous cold quantity allocation at the algorithm level, and when necessary, make the PCMS release or absorb latent heat in a specific partition in advance to avoid severe temperature fluctuations or the formation of "hot islands" or "cold islands" in local areas. At the same time, the present invention integrates early perception measures for biosafety risks to monitor whether there are poor seals or accidental opening phenomena inside the box body. When the signal indicates a suspected leak or a sudden drop in temperature in the box body, the control core will immediately send a remote alarm and activate the local emergency locking program to isolate and independently insulate the temperature zone where the highly sensitive drugs are located in the shortest time to prevent the drugs from being exposed to the external environment or cross-contaminated. This multi-level collaborative working mode not only ensures the high availability of the device, but also reserves sufficient interfaces and data mining space for subsequent human-computer interaction and remote monitoring, enabling the present invention to maintain full-precision temperature control of critical biological preparations in various complex transportation scenarios.

[0006] The present invention further incorporates a complete information fusion and prediction evaluation system in terms of software-hardware collaboration and overall operation and maintenance strategies, enabling multi-temperature zone control to not only perform immediate processing based on the current state, but also make predictions about future transportation environments, load changes, and sudden risks based on historical data precipitation and cloud algorithm models. By deploying status identifiers with independent digital signatures in each temperature zone, the present invention uploads various temperature, humidity, vibration, and opening / closing records to the platform-side database with a stable bandwidth, and the distributed data processing module summarizes the time series of multi-temperature zone energy consumption and heat load, automatically forming the optimal storage and transportation temperature curves of various drugs under different external meteorological conditions. Subsequently, the platform will perform cumulative comparison and anomaly detection on these curves. Once it is identified that there may be serious heat conduction imbalance or insufficient cold storage in certain areas, a scheduling instruction can be issued before the box enters the deep attenuation stage, and the underlying control core will pre-elevate the power of relevant semiconductor refrigeration units or activate the emergency heat preservation link in advance to make cold source reserves in a lower temperature range. At the same time, the Internet of Things communication system carried by the present invention can also aggregate data streams from external traffic data, remote environmental sensors, and geographic information platforms, select the optimal logistics route for the loading vehicle through virtual simulation and dynamic path planning methods, and effectively reduce the temperature zone switching pressure caused by detours, traffic jams, or frequent transfers by combining the overall calculation of vehicle fuel consumption, battery power, and box load. If the system monitors a high probability of natural disasters, extreme weather, or traffic accident threats, it will trigger the warning mode, push the estimated remaining cold energy and drug safety limits to the relevant management terminals in a timely manner, remind the operators to make vehicle replacement or batch transfer plans, and temporarily put the refrigeration modules in non-core temperature zones into dormancy when necessary to concentrate all cold energy to ensure the biological activity of the most critical drugs. Through this system integrating prediction evaluation, intelligent control, and cloud algorithm iteration, the present invention can not only adapt to various extreme meteorological environments and complex road networks, but also perform adaptive maintenance on the box hardware state, perform online detection and remote software updates regularly according to the usage frequency and equipment aging status, thereby significantly extending the device life and ensuring the high efficiency and stability of its various functions during long-term use. Generally speaking, the present invention intensifies the exploration of multi-stage refrigeration and composite phase change heat preservation structures at the hardware layer, and realizes the global intelligent control of the multi-temperature zone transportation process through the acquisition of multi-dimensional real-time data and cloud model algorithms at the software layer, enabling the pharmaceutical cold chain industry to complete cross-regional and cross-climate zone drug distribution tasks in a more flexible and predictable manner under the background of pursuing multi-category, biological safety, and high-performance operation, fully demonstrating the technical creativity and industrial value of the next-generation medical Internet of Things cold chain system. BRIEF DESCRIPTION OF THE DRAWINGS

[0007] The drawings herein are incorporated into the specification and form a part of the specification, indicating the embodiments consistent with the present invention and used together with the specification to explain the principles of the present invention.

[0008] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the accompanying drawings required in the description of the embodiments or the prior art. Obviously, for those of ordinary skill in the art, without creative efforts, other drawings can also be obtained based on these drawings.

[0009] Attached Figure 1 is the overall schematic diagram of the multi-temperature zone medical cold chain system.

[0010] Attached Figure 2 is the schematic diagram of the multi-temperature zone technical route.

[0011] Attached Figure 3 is the multi-temperature zone control flow chart.

[0012] Attached Figure 4 is the data monitoring and remote management flow chart. Specific embodiments

[0013] The following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts belong to the protection scope of the present invention.

[0014] It should be noted that all directional indications (such as up, down, left, right, front, back, etc.) in the embodiments of the present invention are only used to explain the relative positional relationship and movement conditions between components in a specific posture (as shown in the drawings). If this specific posture changes, the directional indication will also change accordingly.

[0015] In addition, the descriptions of "first", "second", etc. in the present invention are only used to distinguish different components, steps or features, so as to clearly explain the technical solutions of the present invention, and should not be construed as indicating or implying their relative importance, nor should it be construed as limiting the quantity of the indicated technical features. Thus, the features defined with "first" and "second" may explicitly or implicitly include at least one of such features.

[0016] The technical solutions between various embodiments can be combined arbitrarily on the premise of not conflicting or being mutually exclusive. When the combined technical solutions are contradictory or cannot be implemented, it should be considered that such a combination of technical solutions does not exist and is not within the protection scope required by the present invention.

[0017] The present invention focuses on the core requirements of collaborative control and refined temperature management in medical cold chain transportation, aiming to meet the different low-temperature requirements of various medical biological agents in the same box or system, and improve the transportation safety and traceability through real-time monitoring and intelligent compensation mechanisms. Most traditional cold chain equipment lacks comprehensive regulation of different temperature zones and is difficult to meet the higher standards of temperature accuracy and heat preservation duration for biological agents, plasma, vaccines, etc. Through the deep combination of composite thermal insulation materials, multi-stage semiconductor refrigeration units, and adaptive algorithms, the present invention creates a multi-temperature zone medical cold chain system suitable for long-distance cross-regional transportation, which can significantly reduce the risk of temperature control failure and achieve remote scheduling management, thus promoting the pharmaceutical logistics to a new level in terms of safety and efficiency. Embodiment 1

[0018] When combined with the overall assembly structure shown in the attached Figure 1 In this embodiment, when combined with the overall assembly structure shown in the attached drawings, the focus is on demonstrating the in-depth cooperation of the multi-temperature zone system between the outer shell S101 and the PCMS thermal insulation layer S104, and how the refrigeration module S102 and the control core S103 perform adaptive scheduling in the drug loading scenario. The outer shell S101 itself is made of several layers of impact-resistant and high-molecular composite materials. After special spraying treatment on its inner wall, it can effectively weaken the thermal radiation coupling, and at the same time, a nano-aerogel coating is set on the outermost layer to reduce the heat flux exchange with the high or low ambient temperature. The refrigeration module S102 located within the outer shell S101 is not a simple stack of semiconductor chips, but realizes elastic refrigeration output for different temperature zones through multi-stage parallel and hierarchical drive technologies; the control core S103 will, at the startup stage, allocate the target temperatures and corresponding initial cooling powers of each partition according to the biological activity levels and temperature requirements of the drugs packed in the box, and then continuously collect various types of data such as temperature and humidity, acceleration, door opening and closing, and stress through the monitoring unit S105 during the operation process. Thus, the system can, on the one hand, master the instant heat load distribution inside the box, and on the other hand, sense the degree of disturbance of the external environment to the box. When it is detected that the box shakes violently or crosses a high-temperature area, S103 will immediately trigger the power tilting mechanism for the refrigeration module S102 to protect the constant temperature safety of the deep cooling zone or the temperature zone where key active drugs are located.

[0019] To more accurately describe the key role of the multi-layer composite insulation material S104 in maintaining the steady state of each temperature zone, this embodiment selects a PCMS configuration with a multi-stage melting point gradient: in the outermost layer closest to the outer shell, a weak phase change material with a phase change temperature slightly higher than the normal temperature is arranged to quickly absorb excess heat when the ambient temperature suddenly rises; in the relatively inner layer, a cryogenic material with a significantly reduced melting point is used to match target ranges such as minus twenty degrees or even lower; a coupling isolation film is added between different phase change materials to limit the heat diffusion rate at the adjacent material interfaces. The interior of the box is separated in depth into multiple temperature zones through S106, and a movable heat insulation partition is installed according to the drug loading characteristics when needed to form a more refined compartment structure, so as to maintain different temperatures specifically for plasma, vaccines or other biological agents respectively.

[0020] In this embodiment, to characterize the depthwise heat conduction process of the gradient phase change layer and assist the control core S103 in performing strategy calculations during real-time scheduling, a model of a non-linear coupled partial differential equation is introduced. This model is used to describe how the temperature of the layer phase change material evolves in space and time: the transient temperature change rate of the material is jointly affected by the heat conduction process and the latent heat effect of phase change, while the density, specific heat capacity and equivalent thermal conductivity of the material itself determine its mass, heat storage capacity and thermal conductivity respectively; at the same time, a comprehensive latent heat coefficient of phase change is also used to characterize the non-linear response intensity of heat absorption and release during phase change, reflecting the heat coupling behavior in different temperature segments. Mathematically, this model uses quantitative descriptions in the spatial dimension and the time dimension to correlate the local heat conduction phenomenon with the overall temperature field distribution. When the control core S103 starts up, it will first perform initial boundary discretization settings on this model; when it detects factors such as a sudden change in the box attitude (such as the acceleration signal feedback through S105) or a sudden rise in the external temperature that cause a sharp change in the heat load of some partitions, it will dynamically correct the boundary conditions of the model. By continuously performing numerical iteration on the temperature field of the multi-layer phase change material partitions, the system can judge which areas have not fully released their latent heat, which positions need additional cold compensation or power load reduction, and use this to guide the refrigeration module S102 to make adjustments in the corresponding partitions, such as by modifying the PWM signal frequency or increasing the current supply, so that the key partitions can return to the predetermined temperature threshold faster.

[0021] In order to avoid the risk of overcooling of common biological agents, the control core S103 will set a priority in the algorithm: first ensure the safety of the deep cold zone and the most temperature-sensitive drugs, while only perform a relatively mild heat dissipation treatment on other temperature zones. This embodiment also infers whether the box is tilted or unstable through the inclination, vibration and other sensors under the monitoring unit S105. Once the detection value exceeds the preset threshold, this situation will be regarded as an additional interference source and acted on the above equation model, so that during the numerical iteration, the increase in the heat transfer gradient in a certain direction caused by the posture change can be identified, and the adjacent partitions are locally pre-cooled or shut down. The strategy is adopted to ensure that a high temperature uniformity can still be maintained during high-speed transportation or repeated loading and unloading, and reduce the risk of drug inactivation caused by "heat island effect" or "cold escape". In summary, through the thermal insulation structure with a gradient phase change layer, a four-stage or multi-stage semiconductor refrigeration module, and a coupling equation analysis that can be dynamically updated, this embodiment can still provide accurate and stable constant temperature protection for each temperature zone in the long-term cross-regional transportation scenario. Example 2

[0022] This embodiment Figure 2Under the technical route, multiple compartment transportation tests for different types of biological agents were carried out to further illustrate the comprehensive effectiveness of the S201 sensing data acquisition and the S205 collaborative scheduling unit. In a certain simulation environment test, the system was placed in a section where the external temperature gradually rose from -10°C to +35°C. During the cross-region transportation simulation of about 16 hours in total, the general refrigerated area represented by S202 was set with a target temperature of 28°C, which mainly stored conventional vaccines and some active vitamin preparations; while the cryogenic area represented by S204 was set at -20°C for simulating the long-distance transportation of plasma, protein preparations and highly sensitive drugs that need to be stored at a lower temperature. According to the initial configuration, the core control algorithm would automatically reduce the refrigeration frequency of the cryogenic area when the external temperature was below 0°C, allowing the PCMS multi-layer thermal insulation material and the passive phase change buffer to play a leading role, so as to better save power in the initial stage of transportation. When the external temperature gradually climbed to about 25°C, the system obtained through S201 that the rising rate of the external temperature and humidity curve of the box body was greater than 2°C / hour, and then updated the energy consumption prediction model in the S203 core control logic, estimating that if the cryogenic area continued to maintain the same refrigeration power in the next 3 hours, it would form an additional consumption of about 15% of the overall power reserve; at the same time, although the real-time temperature of the general refrigerated area remained at 4.2°C, due to the disturbance of the unpacking operation and environmental changes, its estimated cooling demand would fluctuate by about ±1°C. Based on this, the system sent a dynamic scheduling instruction to the semiconductor refrigeration unit through S205: giving priority to ensuring that the temperature of the -20°C cryogenic area does not exceed the range of ±0.5°C, and increasing the latent heat release speed of the phase change material in the insulation area of the 28°C area, so as to reduce the power consumption in the medium temperature section. Subsequently, the data record showed that the actual temperature of the cryogenic area could still be maintained within the fluctuation range of -19.8°C to -20.2°C after 4 hours, and the temperature of the general refrigerated area was stable between 2.5°C and 6.8°C, and the overall power consumption decreased by about 12% compared with the control scheme without using the dynamic scheduling strategy.

[0023] In this embodiment, a high-load interference scenario is specifically set up. Reagents exceeding the rated mass limit are added to the cryogenic zone, and the operation of frequently opening and closing the box door is simulated, so that S201 continuously receives multiple signals of rapid temperature drop and inclination change. After receiving these data, the core control algorithm immediately adjusts the phase change heat resistance channels between adjacent temperature zones, and directs the excess cooling capacity into the cryogenic sub-compartment to offset the heat intrusion caused by the additional load. Therefore, the peak value of the semiconductor refrigeration output required in the S204 cryogenic zone only appears in a short period of time. Thanks to the active "cooling release" of the phase change material, the actual high-power consumption period is shortened by nearly one-third compared with the traditional scheme. At the same time, when the local temperature of the edge temperature layer rises due to the opening and closing of the box, the system will automatically dispatch the heat preservation potential of the medium temperature zone to assist in hedging the heat, so as not to cause additional disturbance to the cryogenic compartment. When the transportation is approaching the end, the core control algorithm will also gradually reduce the overall current duty cycle in advance according to the information that the external temperature is gradually dropping, and switch to the cruise maintenance mode, so that when the box finally reaches the destination, the temperature of each temperature zone deviates only slightly from the initial setting (about ±0.4°C in the general refrigerated zone and about ±0.7°C in the cryogenic zone). These test data will be transmitted back to the system background via the cloud after the transportation is completed for further statistics and trend analysis, providing a guiding basis for subsequent route planning and low-power management. Generally speaking, this embodiment Figure 2 The multi-temperature zone technical route shown in cooperation with the numerical prediction model successfully verifies the adaptive ability of the system in dealing with cold quantity competition in different temperature zones, sudden changes in the external climate or interference from opening and closing the box. It can not only safely guarantee the safe temperature range of key drugs, but also achieve remarkable improvements in energy consumption control and material potential release. Embodiment 3

[0024] When combined with the attached Figure 3 In this embodiment, the focus is on the automatic execution and abnormal response mechanism of the multi-temperature zone control process in a more complex and dynamic environment. S301 is at the starting point of the process. After the box completes the preset initialization operation, the control core will determine the number of temperature zones to be enabled and their respective temperature thresholds according to the drug list and the transportation route information synchronized with the cloud. S302 corresponds to the real-time data acquisition link, obtaining current temperature and humidity, box door status, power consumption rates in the cryogenic zone and the medium cryogenic zone, etc. from the multi-functional sensor array located in different areas of the box, and transmitting them to the main control CPU through the high-speed bus.

[0025] In an actual test, the system carried three types of biological agents: the first type was immunoglobulin, which needed to be maintained at about -20°C; the second type was highly active vaccines, which required a constant temperature environment of 28°C; the third type was some auxiliary material solutions, which could be stored in a relatively wide temperature range of 8 - 12°C. When the control core entered the S303 analysis stage, it first calculated the required heat load ratios for the three types of agents respectively according to the sensing data obtained in S302 and combined with the temperature requirements of the categories written in the packing list, and set different priority levels according to their activity and volatility. At this time, since the loading capacity far exceeded the normal level and the environmental temperature happened to fluctuate violently, there was a significant power demand in the cryogenic zone, while the medium-temperature zone and the loose zone only needed intermittent refrigeration occasionally to stabilize within the preset range. S303 would call the improved thermal coupling equation, historical temperature control curves, and real-time sensor calibration parameters to map the cooling requirements of the three types of agents onto the power distribution scheme of the multi-stage thermoelectric cooling unit.

[0026] When the algorithm determined that there was a tendency for the temperature in the cryogenic zone to exceed the limit or the latent heat that could be released by the phase change material had not been exhausted, the control core would immediately issue a high-priority instruction to the S102 refrigeration component in the S304 stage: increase the current upper limit and duty cycle in the cryogenic zone, limit the power upper limit in the medium-temperature zone, and notify the isolation film nested in the PCMS thermal insulation layer to moderately slow down the heat transfer speed between specific layers. At the same time, in S304, the heat insulation partition between adjacent compartments would also be called to minimize the potential impact of temperature fluctuations on other partitions, ensuring that the highly active vaccines could still be stabilized within the established 2 - 8°C range.

[0027] In the S305 stage, the system would continuously detect abnormal signals from S302, including external abnormal climate (such as heavy rain or extreme heat) information, over-temperature alarms of sensors, or the attitude sensor indicating that the box was tilted significantly, etc. Once the temperature in a certain temperature zone was difficult to drop or there was an instantaneous peak, the control core would immediately trigger the emergency cold storage unit to let the cryogenic phase change material release cold, while reminding the medium-temperature zone to reduce the heat dissipation power and giving priority to maintaining the stability of the critical drug area. If a seal failure or the box door was repeatedly opened and closed in an unauthorized state was detected, the system would record the corresponding data and issue an abnormal warning on the cloud platform. Since Figure 3 in fact, S302 to S305 was a high-speed cycle, and data collection and analysis would be re-executed at each key time slice (usually 5 - 10 seconds) during the vehicle transportation process, so even if the external environment changed rapidly, the multi-temperature zone temperatures inside the box could still be corrected in time.

[0028] When S305 determines that the environmental interference weakens and there is no risk of overheating or overcooling in all temperature zones, the system enters the end state of S307 to complete this round of closed-loop regulation, and then returns to S301 to start a new cycle. In case of major emergencies, such as a complete cut-off of the refrigeration power supply or accidental damage to the cold storage material in a certain partition, S306 will execute the forced locking and emergency cooling capacity centralized distribution strategy in the abnormal branch to protect the most sensitive drugs from inactivation and report the alarm information to the cloud background to prompt the backup plan or the operation of switching to the spare box body.

[0029] In the actual test of this embodiment, after statistics, within about 24 hours of the transportation period, the proportion of the three types of preparations within their respective target temperature ranges is above 98%. Among them, the fluctuation in the cryogenic zone is about ±1.2°C, the fluctuation range in the medium-temperature zone is within ±1.0°C, and the loose zone basically remains in the range of 9 - 12°C, providing a very high safety margin for the preservation requirements of drugs within this range. In addition, the cryogenic sub-compartment that might originally consume a large amount of energy still reduces the energy consumption by about 13% through the dynamic power allocation and the PCMS latent heat release mechanism after encountering external high temperatures and frequent opening of the lid multiple times, demonstrating that the multi-temperature zone adaptive process of the present invention has very prominent practical value in balancing medical active substances and large-scale operation efficiency. Generally speaking, this embodiment not only shows how to implement the Figure 3 circular interaction from S301 to S307 in the process, but also further verifies the feasibility of achieving "precision stability maintenance" relying on multi-stage semiconductor refrigeration and sub-compartment thermal insulation materials in abnormal situations, effectively meeting the rigid requirements of multiple clinical drugs for low-temperature continuity and dynamic environment adaptation during long-distance transportation. Embodiment 4

[0030] In combination with the Figure 4 data monitoring and remote management process shown, this embodiment further highlights the information interaction of the system in a distributed environment and the cloud strategy optimization in a high-load transportation scenario. S401 initially summarizes and compresses all sensing data inside and outside the multi-temperature zones, including not only the temperature curve and humidity change, but also derivative indicators such as the working current of each refrigeration subunit, the release progress of the PCMS phase change material, and the box body attitude. Through wireless transmission S402, this data is sent to the cloud cluster in real-time or near real-time for the cloud's S403 to perform algorithm analysis and fault prediction.

[0031] During an inter-provincial high-speed transportation test, the box passed through multiple climate zones over a transportation distance of up to 1,200 kilometers. The transportation route was in a busy section, with many mid-way stops and frequent sudden accelerations and decelerations. S401 performs a data-packing operation at the end of the box every 5 seconds, integrating the -20°C environment of the multi-temperature deep-freezing compartment, the 2-8°C area of the vaccine compartment, and the energy consumption status of the auxiliary insulation area into a single data record, containing up to more than 200 fields (such as the remaining cold storage capacity of the compartment, the readings of the tilt gyroscope, etc.). Through the redundant parallel mode of the Cat-1 network and the 4G network, S402 can automatically select the optimal communication channel when driving on the highway or in areas with weak network coverage, reducing the situation of disconnection or excessive delay. After receiving the data packet, the cloud S403 immediately calls the distributed cluster for temperature anomaly detection and route congestion prediction based on historical records and real-time information. If it detects severe congestion or unexpected closure on a certain section of the road, it reads the time-consuming of the alternative route from the traffic data interface and estimates the continuous energy consumption of the box as the ambient temperature rises. After the operation is completed, S403 issues a scheduling instruction to S405, instructing the box to pre-strengthen the deep-freezing refrigeration power or temporarily increase the melting rate of the phase change material in the upcoming high-temperature or delay situation, reducing the risk of overheating of the box caused by subsequent detention.

[0032] When the system enters the evening period and the external temperature gradually stabilizes, the cloud finds that the instantaneous power peak has significantly decreased during the fitting analysis of the multi-temperature zone temperature curve and the energy consumption curve. The deep-freezing compartment has a surplus capacity of about 15% while maintaining the -20°C state. Therefore, with the confirmation of the S404 remote management and multi-party supervision terminal, the cloud returns the scheduling instruction to S405, requiring the box to enter the energy-saving mode: reducing the duty cycle of the deep-freezing compartment and gradually releasing the cold energy of the PCMS phase change material, saving a large amount of electricity while maintaining the temperature stability of this compartment. During this process, if the system monitors that there is no load demand in a certain temperature zone for a long time, it can suggest putting it into sleep mode to further reduce energy consumption. When the transport vehicle arrives at the destination early the next morning, the average temperature of the deep-freezing compartment only deviates from the set value by about ±0.8°C, while the vaccine compartment has always remained in the range of 4.0 - 6.5°C. The remaining power of the box is 11% higher than the control scheme without cloud scheduling, leaving enough margin for subsequent short-distance connection or temporary storage.

[0033] This embodiment also sets up a machine learning-based anomaly retrieval module in the cloud background to analyze whether there are hidden cold chain breakpoints or potential failure trends in long-term operating data. For example, if there are frequent peak energy consumption but no significant temperature fluctuations in a batch of boxes, it indicates that there may be hidden dangers of PCMS aging or refrigeration module efficiency attenuation; if it is found that high vibration alarms always appear in the deep cold zone under specific weather conditions, it indicates that under relevant road conditions, the box should be properly fixed or idle cold storage should be scheduled in advance to prevent temperature overshoot. After pre-processing in S403, the cloud sends a comprehensive diagnostic report to the multi-party supervision end S404 to assist the operation and maintenance team in timely maintenance or adjustment of subsequent transportation plans. The above test results will also be sent to users at all levels in the form of data visualization, so that hospitals, pharmaceutical companies and regulatory authorities can jointly evaluate whether it is necessary to upgrade the box structure or replace the phase change material.

[0034] After reaching the end point, the system Figure 4 The process will permanently write the final summarized transport log into the cloud database. If there are subsequent quality disputes or compliance inspections in the transportation process, the temperature records, energy supply status and manual operation traces of each compartment in each time period can also be traced through the log. This embodiment clearly shows the scalability of the present invention in a large-scale cross-regional logistics environment: through the Internet of Things data fusion and cloud-based big data algorithm analysis, not only can multiple temperature zones be managed in-process and post-process, but also the recognition of model parameters such as interval power configuration, phase change material life and refrigeration efficiency can be continuously iterated, so that the multi-temperature zone medical cold chain system has adaptive tuning capabilities during long-term operations. Comparing the final test results with the control solution without remote management, the risk of temperature over-limit is reduced by about 38% and the average energy consumption is reduced by more than 10%, highlighting the significant efficiency and safety value brought by the present invention in actual application scenarios. Example 5

[0035] This embodiment first considers the need to maintain a temperature of -40°C or even lower. On the basis of the existing four-stage semiconductor refrigeration, a micro-refrigerant circulation unit can be selectively installed as an auxiliary means. When the control algorithm detects that the external ambient temperature is extremely bad and the load in the box is at a high priority for deep cooling, the system will temporarily start the circulation unit to enhance the instantaneous cooling effect. In terms of the configuration of the internal insulation layer of the box, this embodiment recommends laying a composite phase change material with multiple melting points on the inner layer to cover the differentiated latent heat requirements of -20°C to -40°C or even lower temperatures, and arranging a cold-resistant isolation film at the junction of two or more phase change materials to avoid rapid heat conduction caused by mixed melting of adjacent layers. In conjunction with the multi-dimensional sensors described in the first four embodiments, the system can accurately monitor the actual temperature of the deep cold zone, the residual latent heat of the phase change material, and the time series of the required cooling power, and couple this information with the external air temperature and the real-time dynamics of the vehicle in the algorithm to achieve optimization of the cooling capacity distribution in the deep cold mode.

[0036] When high-level biosafety risks are involved, in this embodiment, the interior of the box is compartmentalized again, a separate biological isolation area is set up, and a highly sealed partition structure is introduced, in order to add a biological barrier under the multi-temperature zone strategy. Specifically, a polymer protective film with tear resistance and cryogenic resistance can be attached to the outer layer of the isolation area. Once the damage of the cabin wall or the overturning of the box is detected, the system will send high-priority information to the control center through the real-time alarm mechanism of the present invention and synchronize it remotely to the cloud. Then, the locking of this compartment and the increase of additional refrigeration intensity will be triggered, so that the dangerous specimens or active agents continue to be in an extremely low-temperature dormant state, maximizing the reduction of their diffusion risk. To cooperate with this action, the algorithm can also correspondingly reduce the cooling power of other compartments, so that the limited electric energy reserve of the whole box focuses on ensuring the high-risk drug compartment, ensuring that biosafety is given the highest priority.

[0037] Considering that the sensor itself may experience monitoring delay or malfunction under ultra-low temperature conditions, this embodiment allows redundant temperature measurement circuits to be added at the hardware level and multiple data cross-judgments to be used. Once the temperature reported by a certain temperature measurement circuit deviates significantly from other circuits, the "failed sensing" flag is triggered and the default refrigeration mode is temporarily enabled to maintain a more conservative temperature safety margin in the cryogenic scenario. After the environment recovers or it is determined that the sensor is repaired, it will enter the conventional refined scheduling. In terms of cloud linkage, if the shutdown duration is too long due to path congestion or vehicle failure during long-distance transportation, the cloud will also predict in advance the remaining cold energy of the phase change material. If it is estimated that it cannot support the next stop, a high-priority scheduling instruction will be automatically issued, requiring the operator to replace the transportation vehicle or add a mobile power supply as soon as possible, in order to prevent the potential biological danger caused by the delayed temperature rise in the cryogenic compartment.

[0038] This embodiment also focuses on verifying the adaptive ability of the multi-temperature zone box to energy consumption allocation in extreme environments. The measured data shows that when the cryogenic zone maintains -40°C and the external temperature is close to 30°C, with the gradient melting of the phase change material at different levels and the coordinated work of the micro-refrigerant circulation unit, the main control algorithm of the system can reduce the overall operating energy consumption by about 15-20%. Compared with the traditional ultra-low temperature box that solely relies on expanding electric refrigeration, it effectively improves the continuous endurance time and biosafety redundancy, and also reduces the power waste under heavy load conditions. On the other hand, even if the cabin door is abnormally opened or suddenly vibrates during the transportation of highly dangerous pathogen specimens, the safety closing procedures previously set in the isolation area and the multi-level thermal insulation layer can better prevent the spread of contamination. Through this dual route of "hardware protection + software scheduling", the technical challenges faced by the present invention in cryogenic and high-biosafety scenarios are further solved, making the performance of the medical cold chain system more stable in multi-temperature zone coordination and long-distance complex environments.

[0039] In summary, this embodiment does not have new drawings compared with the previous four embodiments. However, it combines the extended application scenarios of cryogenic and biosafety, indicating that as long as corresponding upgrades are made to the hardware configuration and control algorithm in the box, the present invention can easily cope with the harsh conditions of -40°C and even lower temperatures, and still maintain precise control over temperature and potential safety hazards during the transportation of high-risk pathogens or special active drugs, demonstrating the high scalability and strong adaptability of the present invention under extreme conditions, and also providing more comprehensive technical support for the development of the future medical Internet of Things cold chain.

[0040] Obviously, the above embodiments are merely examples given for clear illustration and are not limitations on the implementation manners. For those of ordinary skill in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation manners here. And the obvious changes or modifications derived therefrom still fall within the protection scope of the present invention. Technical terms that need to be explained to facilitate the understanding of the present invention

[0041] For the special concepts and algorithm models used in the multi-temperature zone medical cold chain system of the present invention, some technical terms are not widely popular in general cold chain transportation or refrigeration engineering. To facilitate the understanding of the solutions and their advantages described in this specification, the following terms are now explained.

[0042] Multi-stage thermoelectric refrigeration: It refers to a technology that superimposes multiple layers of P-N junctions (or multiple refrigeration chips) in a single refrigeration unit, and realizes higher temperature difference and stronger refrigeration power through series-parallel connection and hierarchical drive. The "four-stage thermoelectric refrigeration" mentioned in the present invention repeatedly uses the thermoelectric coupling structure in the same refrigeration module, so that the device can still quickly lower the temperature when the working conditions require -20°C or even -40°C.

[0043] PCMS (Phase-Change Multi-Structure) composite thermal insulation material: It means that in the thermal insulation inner liner or the wall layer of the box, multiple phase change materials with different melting points and different heat capacities are compounded and superimposed, so as to store or release latent heat in multiple temperature ranges respectively. The present invention uses the layered structure of this material to adapt to the thermal insulation requirements of different temperature zones, which can not only maintain a constant temperature for a long time, but also achieve steady-state control with the minimum energy consumption when the ambient temperature changes suddenly.

[0044] Multi-temperature zone collaborative regulation: In the same cold chain device, for partitions with significantly different temperature requirements from each other (such as 2 - 8°C and -20°C), with the help of an independent sensor network and a hierarchical refrigeration unit, temperature detection and power distribution are carried out respectively, and collaborative energy consumption management is completed under the algorithm of the control core. The present invention attempts to balance the cooling requirements of each partition and the global energy-saving goal when multiple partitions are running in parallel.

[0045] Improved thermal coupling equation: It refers to introducing additional non-linear factors such as latent heat of phase change, heat flux interaction, and attitude perturbation on the basis of the temperature gradient to depict the dynamic thermodynamic process formed by the multi-layer material structure of the box body of the present invention and the semiconductor refrigeration. Through discretization and numerical iteration, this equation can guide the refrigeration power regulation and abnormal response of multiple temperature zones in real time.

[0046] Biological safety isolation compartment: In extreme environments or high-risk pathogen specimen transportation scenarios, to reduce biological hazards and cross-contamination, the present invention conducts closed physical isolation on some cryogenic zones and combines online monitoring with emergency closing strategies to ensure that high-risk substances can still be isolated from other zones in case of temperature runaway or breakage.

[0047] Emergency closing mode: When the system detects serious external interference or abnormal attitude, as well as biological safety risks, the control core can forcibly lock and centrally refrigerate specific temperature zones to protect the activity and safety of drugs or specimens in these zones. This mode is usually linked with cloud alarms to facilitate manual intervention or secondary transportation.

Claims

1. A multi-temperature zone intelligent control medical cold chain system, characterized in that: The system comprises: (1) The housing is constructed as a load-bearing frame with multi-layer thermal insulation properties; (2) at least one multi-stage semiconductor refrigeration module, embedded in the interior of the box shell, for providing graded refrigeration capacity for different temperature zones; (3) PCMS composite thermal insulation structure, which is arranged between the outer shell of the box and the internal space of the multi-temperature zone, and is composed of a plurality of phase change materials with different phase change temperatures, and is used to realize stratified cold storage and release latent heat in different temperature ranges; (4) a control core, integrated with an algorithm processor, for performing zoned power allocation of the multi-stage semiconductor refrigeration module based on temperature, humidity, and attitude multi-source sensor signals, and correcting the thermal coupling between adjacent temperature zones in real time; (5) A multi-temperature zone internal space, with at least two independent compartments formed in the box through a movable or fixed heat-resistant partition, each compartment corresponding to a medical biological agent with different temperature requirements; (6) a multi-source sensor unit, including temperature and humidity sensors distributed in different temperature zones, a door opening and closing detection device, and an acceleration or inclination detector, for collecting environmental data inside and outside the box and transmitting the data to the control core; (7) Data communication and remote management module, which is used to upload the status information of each temperature zone of the box to the cloud or supervision platform, and receive remote scheduling instructions, triggering emergency alarm and closure mechanism when it is detected that the temperature deviates seriously from the set value or there is a biosafety risk.

2. The multi-temperature zone intelligent control medical cold chain system according to claim 1 is characterized in that: The PCMS composite thermal insulation structure is composed of at least two phase change materials with a phase change temperature difference of not less than 10° C., and a barrier film is provided between adjacent material layers to reduce the phase change diffusion speed and reduce mutual interference between multiple phase change intervals.

3. The multi-temperature zone intelligent control medical cold chain system according to claim 1 or 2, characterized in that: The control core uses an improved thermal coupling equation to perform numerical iteration on each temperature zone, and combines sensor data to adaptively schedule the latent heat release of phase change materials and semiconductor refrigeration power distribution, thereby achieving real-time suppression of temperature overshoot or energy waste in the temperature zone.

4. The multi-temperature zone intelligent control medical cold chain system according to claim 1 is characterized in that: The multi-source sensor unit includes an inclination and vibration detection module, which is used to identify the posture changes of the box in cross-regional transportation or bumpy scenarios. If an abnormal posture is detected, the posture disturbance information is automatically written into the thermal coupling boundary conditions of the control core to timely correct the cold storage and refrigeration power allocation plan of each partition.

5. The multi-temperature zone intelligent control medical cold chain system according to claim 1 is characterized in that: The data communication and remote management module supports at least two wireless transmission methods at the same time, and automatically selects the optimal communication channel according to the transmission delay and signal quality to ensure that the temperature of multiple temperature zones, energy consumption and safety alarm information can be uploaded to the cloud in real time even when the cabinet moves at high speed or the network coverage is unstable.

6. The multi-temperature zone intelligent control medical cold chain system according to claim 1 or 2, characterized in that: A nano-aerogel coating or a polymer weather-resistant film is arranged on the outer side of the box shell to further reduce the disturbance of the external temperature difference on the temperature distribution inside the box, and together with the PCMS composite insulation structure, form a multiple anti-thermal shock barrier.

7. The multi-temperature zone intelligent control medical cold chain system according to claim 1 is characterized in that: A biosafety isolation compartment is added to the deep cold zone of the internal space of the box to meet the ultra-low temperature storage and transportation needs of high-risk pathogens or extremely active preparations. The inner wall of the isolation compartment is equipped with a protective layer with high sealing and additional phase change material barrier, and when damage or unauthorized opening of the cover is detected, forced locking and centralized refrigeration are triggered.

8. The multi-temperature zone intelligent control medical cold chain system according to claim 1 is characterized in that: It also includes a micro-refrigerant circulation unit, which automatically starts when the outside temperature is higher than a specified threshold and the semiconductor refrigeration component is underpowered, and cooperates with the PCMS composite insulation structure to output extreme cold to maintain an ultra-low temperature stable environment in the range of minus 20 degrees to minus 40 degrees.

9. The multi-temperature zone intelligent control medical cold chain system according to claim 1 is characterized in that: The control core also includes an abnormal diagnosis submodule, which is used to compare the temperature curve, energy consumption curve and position trajectory collected by the sensor through a big data model. If a sensor failure, refrigeration efficiency degradation or biosafety leakage risk occurs, an alarm will be issued and the local emergency strategy will be switched to maintain a large temperature safety margin in deep cold areas or highly sensitive areas.

10. The multi-temperature zone intelligent control medical cold chain system according to claim 1, characterized in that: The multi-temperature zone internal space can automatically insert or remove heat-resistant partitions according to the type and batch of medicines, so that a single box can form more than two temperature zones or merge into a larger temperature range when necessary, so as to adapt to the flexible requirements of temperature control range and cabin capacity for long-distance transportation of diversified medical biological preparations.

Citation Information

Cited By

  • Vaccine cold storage AGV operation navigation method and cold storage AGV

    CN121523347A